190 related articles for article (PubMed ID: 30209123)
1. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
Karthikeyan G; Devasenapathy N; Zühlke L; Engel ME; Rangarajan S; Teo KK; Mayosi BM; Yusuf S;
Heart; 2019 Mar; 105(5):363-369. PubMed ID: 30209123
[TBL] [Abstract][Full Text] [Related]
2. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
[TBL] [Abstract][Full Text] [Related]
3. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
[TBL] [Abstract][Full Text] [Related]
4. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
5. Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.
Madelaire C; Schou M; Nelveg-Kristensen KE; Schmiegelow M; Torp-Pedersen C; Gustafsson F; Køber L; Gislason G
Int J Cardiol; 2016 Oct; 221():944-50. PubMed ID: 27441473
[TBL] [Abstract][Full Text] [Related]
6. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
[TBL] [Abstract][Full Text] [Related]
7. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
[TBL] [Abstract][Full Text] [Related]
8. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
[TBL] [Abstract][Full Text] [Related]
9. Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.
Gerakaris A; Mulita F; Koniari I; Artopoulou E; Mplani V; Tsigkas G; Abo-Elseoud M; Kounis N; Velissaris D
Med Arch; 2022 Feb; 76(1):23-28. PubMed ID: 35422570
[TBL] [Abstract][Full Text] [Related]
10. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
Gheorghiade M; Fonarow GC; van Veldhuisen DJ; Cleland JG; Butler J; Epstein AE; Patel K; Aban IB; Aronow WS; Anker SD; Ahmed A
Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708
[TBL] [Abstract][Full Text] [Related]
11. Digoxin and Mortality in Patients With Atrial Fibrillation.
Lopes RD; Rordorf R; De Ferrari GM; Leonardi S; Thomas L; Wojdyla DM; Ridefelt P; Lawrence JH; De Caterina R; Vinereanu D; Hanna M; Flaker G; Al-Khatib SM; Hohnloser SH; Alexander JH; Granger CB; Wallentin L;
J Am Coll Cardiol; 2018 Mar; 71(10):1063-1074. PubMed ID: 29519345
[TBL] [Abstract][Full Text] [Related]
12. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
Singh S; Moore H; Karasik PE; Lam PH; Wopperer S; Arundel C; Tummala L; Anker MS; Faselis C; Deedwania P; Morgan CJ; Zeng Q; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Dec; 133(12):1460-1470. PubMed ID: 32603789
[TBL] [Abstract][Full Text] [Related]
13. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
[TBL] [Abstract][Full Text] [Related]
14. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
[TBL] [Abstract][Full Text] [Related]
15. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.
Adedinsewo D; Xu J; Agasthi P; Oderinde A; Adekeye O; Sachdeva R; Rust G; Onwuanyi A
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004573. PubMed ID: 28500174
[TBL] [Abstract][Full Text] [Related]
16. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes of patients with rheumatic heart disease.
Liu C; Lai Y; Wu D; Fu R; Li Y; Li H; Guan T; Shen Y
ESC Heart Fail; 2021 Dec; 8(6):5338-5351. PubMed ID: 34545695
[TBL] [Abstract][Full Text] [Related]
17. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
[TBL] [Abstract][Full Text] [Related]
18. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
Allen LA; Fonarow GC; Simon DN; Thomas LE; Marzec LN; Pokorney SD; Gersh BJ; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Chang P; Peterson ED; Piccini JP;
J Am Coll Cardiol; 2015 Jun; 65(25):2691-8. PubMed ID: 26112191
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.
Ziff OJ; Lane DA; Samra M; Griffith M; Kirchhof P; Lip GY; Steeds RP; Townend J; Kotecha D
BMJ; 2015 Aug; 351():h4451. PubMed ID: 26321114
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
Botis M; Kartas A; Samaras A; Akrivos E; Vrana E; Liampas E; Papazoglou AS; Moysidis DV; Papanastasiou A; Baroutidou A; Karvounis H; Tzikas A; Parissis J; Drakos SG; Giannakoulas G
Hellenic J Cardiol; 2022; 68():25-32. PubMed ID: 36037999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
